ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,727.40
-0.10%
US Tech 100
19,426.40
0.06%
Dow Jones
41,966.00
-0.57%
Brent Oil
72.59
-2.64%
Bitcoin
63,564.98
-1.09%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Science Group Plc (SAG) Quote

Science Group Plc

Science Group Plc (SAG)

Sterling Metals Corp
465.00
0.00
(0.00%)
Closed September 25 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
465.00
Bid
460.00
Ask
470.00
Volume
11,936
465.00 Day's Range 465.00
368.00 52 Week Range 492.00
Market Cap
211.53M
Previous Close
465.00
Open
465.00
Last Trade
900
@
460.1
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
36,751
Shares Outstanding
45,490,405
Dividend Yield
1.72%
PE Ratio
38.30
Earnings Per Share (EPS)
0.12
Revenue
133.07M
Net Profit
5.52M

About Science Group Plc

Sector
Business Consulting Svcs,nec
Industry
Technology Diversified
Website
www.sciencegroup.com
Headquarters
Cambridge, Gbr
Founded
1986
Science Group Plc is listed in the Business Consulting Svcs sector of the London Stock Exchange with ticker SAG. The last closing price for Science was 465p. Over the last year, Science shares have traded in a share price range of 368.00p to 492.00p.

Science currently has 45,490,405 shares outstanding. The market capitalization of Science is £211.53 million. Science has a price to earnings ratio (PE ratio) of 38.30.

Ask ADVFN Intelligence (AI)

SAG Latest News

More News

Science Group PLC Transaction in Own Shares

Science Group PLC 25 September 2024       25 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

10 hours ago
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 24 September 2024       24 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 24 2024
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 23 September 2024       23 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 23 2024
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 20 September 2024       20 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 20 2024
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 19 September 2024       19 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 19 2024
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 18 September 2024       18 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 18 2024
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 17 September 2024       17 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 17 2024
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 13 September 2024       13 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 13 2024
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 12 September 2024       12 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 12 2024
RNS Regulatory News

Science Group PLC Transaction in Own Shares

Science Group PLC 11 September 2024       11 September 2024   Science Group plc (the "Company" or "Science Group")   Transaction in own shares     Science Group plc (AIM:SAG) announces that...

September 11 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-20-4.1237113402148548546525005474.76579459DE
4-23-4.713114754148849246537803485.4575253DE
12306.8965517241443549239536751451.45400858DE
266415.960099750640149239533607443.45439553DE
525814.250614250640749236833813420.03178556DE
156-10-2.1052631578947549235030276410.5269503DE
260273142.187519249216533401367.88793924DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OVBOvoca Bio Plc
1.175p
(74.07%)
12.42M
PPSProton Motor Power Systems Plc
0.65p
(62.50%)
1.54M
GBPGlobal Petroleum Limited
0.1925p
(37.50%)
305.2M
LNDLandore Resources Limited
3.85p
(27.27%)
2.76M
TRLSTrellus Health Plc
1.45p
(26.09%)
14.35M
NTQEnteq Technologies Plc
4.90p
(-45.56%)
1.48M
SYMESupply@me Capital Plc
0.004p
(-43.26%)
4.85B
DCTADirecta Plus Plc
11.50p
(-28.13%)
381.15k
AYMAnglesey Mining Plc
1.05p
(-22.22%)
2.61M
CRTACirata Plc
24.50p
(-15.22%)
1.22M
SYMESupply@me Capital Plc
0.004p
(-43.26%)
4.85B
NTVONativo Resources Plc
0.0026p
(4.00%)
1.28B
CLONClontarf Energy Plc
0.049p
(-1.01%)
817.89M
HE1Helium One Global Ltd
1.14p
(12.32%)
310.59M
PREMPremier African Minerals Limited
0.0515p
(0.98%)
309.8M

Discussion

View Full Feed
flipper44 flipper44 4 minutes ago
BTW: Yescarta
The FDA updated the approval for Yescarta (axicabtagene ciloleucel) in April 2022 to allow it to be used as a second-line treatment. This was the first time a CAR T-cell therapy was approved for use as a second-line treatment.

In other words, not SOC.
NWBO
BIOCHEMUP BIOCHEMUP 4 minutes ago
10K 0.002
10K 0.0004
RSPI
TrendTrade2016 TrendTrade2016 4 minutes ago
TGRP GETTING SMOKED...WARNED
TGRP
gfp927z gfp927z 4 minutes ago
>>> Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium


PR Newswire

September 24, 2024


https://finance.yahoo.com/n
ACXP
RIGATONI RIGATONI 4 minutes ago
Looks like they recently terminated their offering...

RAADR, INC. (Form: 1-Z, Received: 09/17/2024 12:39:42) (otcmarkets.com)


certifies that it meets all of the conditions for termination of Regulation A reporting specified in
jedijazz jedijazz 4 minutes ago
$XXII BIG NEWS: $XXII 22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume
CMO customer adds to previously announced cigarette export business with combined volume significantly adding to profitability

Mocksville, North Carolina--(Newsfile Corp. -
XXII
jedijazz jedijazz 4 minutes ago
$XXII BIG NEWS: $XXII 22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume
CMO customer adds to previously announced cigarette export business with combined volume significantly adding to profitability

Mocksville, North Carolina--(Newsfile Corp. -
XXII
Monksdream Monksdream 4 minutes ago
FAAS 10 day hourly
https://investorshub.advfn.com/uimage/uploads/2024/9/25/gwcrrIMG_2125.gif
FAAS
Petroleum2024 Petroleum2024 4 minutes ago
What did hkd do? What's your price target for xhg? Thanks
XHG
Rainer Rainer 5 minutes ago
nice volume
RDAR
MartinLutherKing MartinLutherKing 5 minutes ago
Go big or go home
RNAZ
misanthrope misanthrope 5 minutes ago
What are your expectations?

Regarding financials, don't expect any until the next annual report is due - BIEL no longer files quarterly reports. Regarding news - there likely isn't anything KW is willing or able to report. She has stated when she has news that she can release she
BIEL
DawgTrading DawgTrading 5 minutes ago
Ill take a look around and hunt some down.
CBMJ
TRIPLE_ZERO_SEVEN TRIPLE_ZERO_SEVEN 5 minutes ago
Claims that it's hidden and the TA doesn't even know about it yet. He also claims inside information of a 1 for 2000 reverse split coming. Been claiming these things for at least a year now.
AAPJ
learningcurve2020 learningcurve2020 5 minutes ago
Btw, I hope I'm wrong in this one because I thought their T product was on the right track. But it feels to me like everything is being gutted.
MRKR
nyt nyt 5 minutes ago
They must've reconsidered... lololol

Some here sound as tho they're
HYPNOTIZED
VPLM
MartinLutherKing MartinLutherKing 5 minutes ago
RNAZ On the nasdaq big time brother,
RNAZ
ElectricJester54 ElectricJester54 5 minutes ago
I don't imagine it will hit a dollar off the bat from what I have read from other posts on here, maybe a couple years from now as the merging business grows and gains more attention. I think the realistic figures I have seen if I receall correctly are around like 0.25 per share, which is still a ton
ZHUD
double_m double_m 5 minutes ago
Good question, but I doubt it. If you follow the cycle, he usually gets issued his shares towards the bottom of the price fall off, and some time before announcing a SH meeting via 14A. Those shares are used to control the vote and aren't sold until after the RS. It's a continuous cycle. If you reme
MULN
docsetc docsetc 5 minutes ago
With Chandra's evasive and dispassionate answers today on 'X', I'm inclined to agree on all points. He could actually be uniting all shareholders, patient and incensed right now, for a huge Adnexus launch, but so far nothing that even remotely resembles true leadership or shareholder interests from
ENZC
TrendTrade2016 TrendTrade2016 6 minutes ago
OUCH...YOU WERE WARNE ABOUT THE TOP RINSE...RUG PULL WITH NO WEEKLY TREND
MONI
blackhawks blackhawks 6 minutes ago
But she doesn't lie more than the Orange Felon so, as usual, no f'ing point for you.
alwayswatching1 alwayswatching1 6 minutes ago
We are all amariaddicts. Otherwise why in the world would any of us still be here. Except of course our beloved paid bashers and those bitter souls who sold for epic losses.
AMRN
manibiotech manibiotech 6 minutes ago
In 2023, several cancer and oncology drugs were approved by the FDA. Here are some notable examples:

1. **Epkinly (epcoritamab-bysp)**
Approved on May 19, 2023, Epkinly is used to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymp
NWBO
oldman69 oldman69 6 minutes ago
Good job trading 101!
DJT

Your Recent History

LSE
SAG
Science
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved